- Changes in lipid biomarkers, liver stiffness and steatosis following sodium-glucose cotransporter two inhibitor therapy in type two diabetes
- Browse: 66 Download: 172 Issue Date: 2026-10-21
- Gut microbiome in patients with cirrhosis and clinically significant portal hypertension: A pilot study
- Browse: 54 Download: 194 Issue Date: 2026-10-21
- Autoimmune hepatitis in the context of systemic lupus erythematosus: A narrative review of overlap syndrome and lupus-associated hepatitis
- Browse: 53 Download: 136 Issue Date: 2026-10-21
- Imbalance of the coagulation-anticoagulation-fibrinolytic system: Pathogenesis and therapeutic approaches in progressive liver injury
- Browse: 53 Download: 145 Issue Date: 2026-10-21
- Hyperammonemia as a potential contributor to fatigue in metabolic dysfunction-associated steatotic liver disease: A mechanistic review
- Browse: 50 Download: 148 Issue Date: 2026-10-21
- Splenic stiffness measurement to predict decompensation in compensated advanced chronic liver disease
- Browse: 131 Download: 494 Issue Date: 2026-09-17
- From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
- Browse: 104 Download: 370 Issue Date: 2026-09-17
- Hepatocellular carcinoma with obstructive jaundice: Biliary drainage and multimodal therapy
- Browse: 112 Download: 342 Issue Date: 2026-09-17
- Molecular characteristics and carcinogenic mechanisms of aflatoxin B1-associated hepatocellular carcinoma: Recent advances
- Browse: 98 Download: 377 Issue Date: 2026-09-17
- Predicting pancreatic fistula risk after splenectomy in cirrhotic splenomegaly: Surgical anatomy and implications
- Browse: 97 Download: 342 Issue Date: 2026-09-17
- Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
- Browse: 131 Download: 502 Issue Date: 2026-08-18
- Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease and fibrosis in recently diagnosed type 2 diabetes
- Browse: 108 Download: 628 Issue Date: 2026-08-18
- Effect of hepatic venous pressure gradient in different hepatic venous branches on assessing portal hypertension in cirrhotic patients
- Browse: 105 Download: 718 Issue Date: 2026-08-18
- Metabolic dysfunction-associated steatotic liver disease and the consequence of extra-hepatic malignancy
- Browse: 131 Download: 360 Issue Date: 2026-08-18
- Peribiliary and colonic crypt glands in primary sclerosing cholangitis and inflammatory bowel disease pathogenesis: New research perspectives
- Browse: 93 Download: 454 Issue Date: 2026-08-18
- Poria in Fuling Zexie decoction for treating metabolic dysfunction-associated steatotic liver disease: Underlying mechanisms and key bioactive substances
- Browse: 155 Download: 827 Issue Date: 2026-07-24
- Activated cGAS-STING signaling promotes malignancy in metabolic dysfunction-associated fatty liver disease via mitochondrial DNA and immune cell dysfunction
- Browse: 132 Download: 754 Issue Date: 2026-07-24
- Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism
- Browse: 152 Download: 757 Issue Date: 2026-07-24
- Computed tomography-based correction of the body mass index improves malnutrition detection in patients with cirrhosis and ascites
- Browse: 131 Download: 782 Issue Date: 2026-07-24
- Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation
- Browse: 134 Download: 628 Issue Date: 2026-07-24